These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 10092689

  • 1. Morbidity from asthma in relation to regular treatment: a community based study.
    Walsh LJ, Wong CA, Cooper S, Guhan AR, Pringle M, Tattersfield AE.
    Thorax; 1999 Apr; 54(4):296-300. PubMed ID: 10092689
    [Abstract] [Full Text] [Related]

  • 2. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
    Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Paré P.
    CMAJ; 2001 Mar 06; 164(5):625-31. PubMed ID: 11258208
    [Abstract] [Full Text] [Related]

  • 3. Which patients are prescribed inhaled anti-asthma drugs?
    Roberts SJ, Bateman DN.
    Thorax; 1994 Nov 06; 49(11):1090-5. PubMed ID: 7831622
    [Abstract] [Full Text] [Related]

  • 4. Symptomatic asthma: attendance and prescribing in general practice.
    Nolan D, White R.
    Respir Med; 2002 Feb 06; 96(2):102-9. PubMed ID: 11860166
    [Abstract] [Full Text] [Related]

  • 5. Implementing the British Thoracic Society's guidelines: the effect of a nurse-run asthma clinic on prescribed treatment in an English general practice.
    Dickinson J, Hutton S, Atkin A.
    Respir Med; 1998 Feb 06; 92(2):264-7. PubMed ID: 9616523
    [Abstract] [Full Text] [Related]

  • 6. Asthma management and morbidity in Australian general practice: the relationship between patient and doctor estimates.
    Bauman A, Cooper C, Bridges-Webb C, Tse M, Miles D, Bhasale A, Pollock M.
    Respir Med; 1995 Nov 06; 89(10):665-72. PubMed ID: 8570880
    [Abstract] [Full Text] [Related]

  • 7. The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma.
    van Boven JF, Hiddink EG, Stuurman-Bieze AG, Schuiling-Veninga CC, Postma MJ, Vegter S.
    Int J Clin Pharm; 2013 Dec 06; 35(6):1075-82. PubMed ID: 23888347
    [Abstract] [Full Text] [Related]

  • 8. Asthma in emergency department. Guidelines, physicians and patients.
    Cavazos Galván M.
    Rev Alerg Mex; 2006 Dec 06; 53(4):136-43. PubMed ID: 17137189
    [Abstract] [Full Text] [Related]

  • 9. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005535. PubMed ID: 16235410
    [Abstract] [Full Text] [Related]

  • 10. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
    Sadatsafavi M, Lynd LD, Marra CA, FitzGerald JM.
    Thorax; 2014 Apr 19; 69(4):328-34. PubMed ID: 24281327
    [Abstract] [Full Text] [Related]

  • 11. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases.
    Anthonisen NR, Woodlrage K, Manfreda J.
    Can Respir J; 2005 Mar 19; 12(2):69-74. PubMed ID: 15785794
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology.
    Laumann JM, Bjornson DC.
    Ann Pharmacother; 1998 Dec 19; 32(12):1290-4. PubMed ID: 9876808
    [Abstract] [Full Text] [Related]

  • 13. Adherence to asthma guidelines in general practices.
    Roghmann MC, Sexton M.
    J Asthma; 1999 Jun 19; 36(4):381-7. PubMed ID: 10386502
    [Abstract] [Full Text] [Related]

  • 14. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP, Whale CI, Tattersfield AE.
    Drug Saf; 2004 Jun 19; 27(10):689-715. PubMed ID: 15350154
    [Abstract] [Full Text] [Related]

  • 15. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM.
    Curr Opin Pulm Med; 2008 Jan 19; 14(1):57-63. PubMed ID: 18043276
    [Abstract] [Full Text] [Related]

  • 16. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
    van der Molen T, Postma DS, Turner MO, Jong BM, Malo JL, Chapman K, Grossman R, de Graaff CS, Riemersma RA, Sears MR.
    Thorax; 1997 Jun 19; 52(6):535-9. PubMed ID: 9227720
    [Abstract] [Full Text] [Related]

  • 17. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.
    Walsh LJ, Wong CA, Pringle M, Tattersfield AE.
    BMJ; 1996 Aug 10; 313(7053):344-6. PubMed ID: 8760745
    [Abstract] [Full Text] [Related]

  • 18. Low-dose inhaled corticosteroids and the prevention of death from asthma.
    Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B.
    N Engl J Med; 2000 Aug 03; 343(5):332-6. PubMed ID: 10922423
    [Abstract] [Full Text] [Related]

  • 19. The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands.
    de Vries TW, Tobi H, Schirm E, van den Berg P, Duiverman EJ, de Jong-van den Berg LT.
    Eur J Clin Pharmacol; 2006 Jan 03; 62(1):51-5. PubMed ID: 16365748
    [Abstract] [Full Text] [Related]

  • 20. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug 03; 40(8):62-4. PubMed ID: 12216339
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.